Comorbidities in Anti-Cyclic Citrullinated Peptide Positive At-Risk Individuals Do Not Differ from Those Patients with Early Inflammatory Arthritis

OBJECTIVES: To compare comorbidities in a cohort of cyclic citrullinated peptide (CCP) antibody positive patients without or prior to onset of inflammatory arthritis (IA) to those in patients with early IA. METHODS: Baseline data from two established cohorts were used. The first recruited people at...

Descripción completa

Detalles Bibliográficos
Autores principales: Twigg, Sarah, Nikiphorou, Elena, Nam, Jackie L., Hunt, Laura, Mankia, Kulveer, Pentony, Peta Elizabeth, Freeston, Jane E., Tan, Ai Lyn, Emery, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825886/
https://www.ncbi.nlm.nih.gov/pubmed/29516000
http://dx.doi.org/10.3389/fmed.2018.00035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5825886/
https://www.ncbi.nlm.nih.gov/pubmed/29516000
http://dx.doi.org/10.3389/fmed.2018.00035

Ejemplares similares